PPARG and lung carcinoma: Per, we emphasize pioglitazone and telmisartan as distinctive ligands for the NSCLC repressor PPARG in the current in-silico targeted delivery investigation; therefore, we will use chem-bio-informatics35 to find out how well the chosen drugs work for treating lung cancer when delivered by exosome cargo, before testing them in the lab.